Moberg Pharma AB (MOB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Moberg Pharma AB (Moberg Pharma), formerly Moberg Derma AB, is a pharmaceutical company. The company provides commercializes proprietary, acquired and licensed products. It provides treatment of skin diseases. Moberg Pharma treats fungal infection or psoriasis, discolored and fungus-damaged nails, Fast relief of pain and itch, Waterproof liquid bandage, minor skin irritations, diaper rash, skin irritation and rash and dry feet and cracked heels in one step. The company works in collaboration to develop Oral mucositis for the treatment of pain in the oral cavity. It offers licencing in and licencing out services. The company markets its products in Europe, South America, Africa, the Middle East and others. Moberg Pharma is headquartered in Stockholm, Sweden.

Moberg Pharma AB (MOB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

it derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 5
List of Figures 5
Moberg Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Moberg Pharma AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Moberg Pharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Moberg Pharma AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Moberg Pharma AB, Medical Devices Deals, 2012 to YTD 2018 10
Moberg Pharma AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Moberg Pharma AB, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Moberg Pharma Acquires DermoPlast from Prestige 13
Moberg Pharma Acquires PediaCare Brands from Strides Pharma for USD5.6 Million 15
Moberg Pharma Acquires Three US OTC Brands from Prestige Brands for USD40 Million 16
Moberg Pharma Acquires Balmex from Chattem for USD3.9 Million 18
Moberg Pharma Acquires Bupivacaine From Oracain 19
Moberg Pharma Completes Acquisition Of Over-The-Counter Brands From Bayer HealthCare For US$4.8 Million 20
Partnerships 21
Moberg Pharma Enters into Agreement with Colep 21
Moberg Extends Distribution Agreement with Menarini for Emtrix 22
Moberg Pharma Extends Distribution Agreement with Berlin-Chemie for Emtrix 23
Moberg Pharma Extends Distribution Agreement With Menarini 24
Moberg Extends Distribution Agreement With Menarini For Kerasal Nail 25
Moberg Extends Distribution Agreement With Paladin Labs For Kerasal Nail 26
Paladin Labs Enters Into Distribution Agreement With Moberg Derma For Emtrix 27
Moberg Derma Enters Into Co-Marketing Agreement With Ana Darou For Emtrix 28
Licensing Agreements 29
Cipher Pharma Enters into Licensing Agreement with Moberg Pharma 29
Cadila Pharma Enters into Licensing Agreement with Moberg Pharma 30
Equity Offering 31
Moberg Pharma to Raise USD16 Million in Private Placement of Shares 31
Moberg Pharma Raises USD8.6 Million in Private Placement of Shares 32
Moberg Pharma Completes Rights Offering Of Shares For US$5 Million 34
Debt Offering 35
Moberg Pharma Raises USD32.8 million in Public Offering of Bonds 35
Asset Transactions 36
Randob Labs Acquires Balmex from Moberg Pharma for USD4.2 Million 36
Strides Shasun Acquires Jointflex, Fergon and Vanquish Brands from Moberg Pharma for USD10 Million 37
Acquisition 38
Altaris Capital Sells Minority Stake in Moberg Pharma 38
Moberg Derma Completes Acquisition Of Alterna From Altaris Capital Partners For US$25 Million 39
Moberg Pharma AB - Key Competitors 41
Moberg Pharma AB - Key Employees 42
Moberg Pharma AB - Locations And Subsidiaries 43
Head Office 43
Other Locations & Subsidiaries 43
Recent Developments 44
Financial Announcements 44
Aug 07, 2018: Moberg Pharma interim report January - June 2018 44
May 08, 2018: Moberg Pharma Interim report January - March 2018 46
Feb 13, 2018: Moberg Pharma Year-end Report 2017 48
Nov 13, 2017: Moberg Pharma interim report January - September 2017 50
Aug 08, 2017: Moberg Pharma: interim report January- June 2017 51
May 09, 2017: Moberg Pharma interim report January - March 2017 53
Feb 14, 2017: Moberg Pharma Year-end report 2016 54
Corporate Communications 56
Aug 13, 2018: Moberg Pharma appoints new chief medical officer 56
Apr 19, 2018: Moberg Pharma Announces Resignation Of Kjell Rensfeldt As VP Research and Development 57
Appendix 58
Methodology 58
About GlobalData 58
Contact Us 58
Disclaimer 58

List Of Tables


Moberg Pharma AB, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Moberg Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Moberg Pharma AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Moberg Pharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Moberg Pharma AB, Deals By Therapy Area, 2012 to YTD 2018 9
Moberg Pharma AB, Medical Devices Deals, 2012 to YTD 2018 10
Moberg Pharma AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Moberg Pharma Acquires DermoPlast from Prestige 13
Moberg Pharma Acquires PediaCare Brands from Strides Pharma for USD5.6 Million 15
Moberg Pharma Acquires Three US OTC Brands from Prestige Brands for USD40 Million 16
Moberg Pharma Acquires Balmex from Chattem for USD3.9 Million 18
Moberg Pharma Acquires Bupivacaine From Oracain 19
Moberg Pharma Completes Acquisition Of Over-The-Counter Brands From Bayer HealthCare For US$4.8 Million 20
Moberg Pharma Enters into Agreement with Colep 21
Moberg Extends Distribution Agreement with Menarini for Emtrix 22
Moberg Pharma Extends Distribution Agreement with Berlin-Chemie for Emtrix 23
Moberg Pharma Extends Distribution Agreement With Menarini 24
Moberg Extends Distribution Agreement With Menarini For Kerasal Nail 25
Moberg Extends Distribution Agreement With Paladin Labs For Kerasal Nail 26
Paladin Labs Enters Into Distribution Agreement With Moberg Derma For Emtrix 27
Moberg Derma Enters Into Co-Marketing Agreement With Ana Darou For Emtrix 28
Cipher Pharma Enters into Licensing Agreement with Moberg Pharma 29
Cadila Pharma Enters into Licensing Agreement with Moberg Pharma 30
Moberg Pharma to Raise USD16 Million in Private Placement of Shares 31
Moberg Pharma Raises USD8.6 Million in Private Placement of Shares 32
Moberg Pharma Completes Rights Offering Of Shares For US$5 Million 34
Moberg Pharma Raises USD32.8 million in Public Offering of Bonds 35
Randob Labs Acquires Balmex from Moberg Pharma for USD4.2 Million 36
Strides Shasun Acquires Jointflex, Fergon and Vanquish Brands from Moberg Pharma for USD10 Million 37
Altaris Capital Sells Minority Stake in Moberg Pharma 38
Moberg Derma Completes Acquisition Of Alterna From Altaris Capital Partners For US$25 Million 39
Moberg Pharma AB, Key Competitors 41
Moberg Pharma AB, Key Employees 42
Moberg Pharma AB, Subsidiaries 43

List Of Figures


Moberg Pharma AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Moberg Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Moberg Pharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Moberg Pharma AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Moberg Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Moberg Pharma AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Moberg Pharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Moberg Pharma AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Moberg Pharma AB, Medical Devices Deals, 2012 to YTD 2018 10

Moberg Pharma AB (MOB) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Moberg Pharma AB (Moberg Pharma), formerly Moberg Derma AB, is a pharmaceutical company. The company provides commercializes proprietary, acquired and licensed products. It provides treatment of skin diseases. Moberg Pharma

USD 250 View Report

Moberg Pharma AB Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Moberg Pharma AB Company Profile is a detailed strategic and analytical report on Moberg Pharma AB. The 2018 version of the report offers detailed insights into the companys strategies, developments,

USD 200 View Report

Xspray Pharma AB (XSPRAY) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Xspray Pharma AB (Xspray Pharma), formerly Xspray Microparticles AB, is a drug development company that develops and commercializes protein kinase inhibitors (PKI) for targeted cancer treatments. The companys drug candidates

USD 250 View Report

Moberg Pharma AB (MOB) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Moberg Pharma AB (Moberg Pharma), formerly Moberg Derma AB, is a pharmaceutical company. The company provides commercializes proprietary, acquired and licensed products. It provides treatment of skin diseases. Moberg Pharma

USD 250 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available